Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Jun 2025 is 650.00% vs -75.00% in Mar 2025
Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is 30.89% vs -29.47% in Mar 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Jun 2025 is 25.44% vs -18.75% in Mar 2025
Interest
QoQ Growth in quarter ended Jun 2025 is -100.00% vs -50.00% in Mar 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025
Compare Quarterly Results Of Cue Biopharma, Inc. With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2025 is 650.00% vs -75.00% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 11.11% vs 92.86% in Jun 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is 30.89% vs -29.47% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 16.67% vs 22.73% in Jun 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2025 is 25.44% vs -18.75% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 10.53% vs 25.20% in Jun 2024
Quarterly - Interest
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025
YoY Growth in quarter ended Jun 2025 has improved from Jun 2024






